Reported Earnings • Feb 10
Third quarter 2026 earnings released: EPS: JP¥17.76 (vs JP¥19.81 in 3Q 2025) Third quarter 2026 results: EPS: JP¥17.76 (down from JP¥19.81 in 3Q 2025). Revenue: JP¥14.7b (up 2.1% from 3Q 2025). Net income: JP¥438.0m (down 10% from 3Q 2025). Profit margin: 3.0% (down from 3.4% in 3Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.7% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Announcement • Jan 06
Saint-Care Holding Corporation to Report Q3, 2026 Results on Feb 09, 2026 Saint-Care Holding Corporation announced that they will report Q3, 2026 results on Feb 09, 2026 Valuation Update With 7 Day Price Move • Nov 17
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to JP¥1,215, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 14x in the Healthcare industry in Japan. Total returns to shareholders of 60% over the past three years. New Risk • Nov 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.5% per year for the foreseeable future. Minor Risks Dividend is not well covered by cash flows (100% cash payout ratio). Share price has been volatile over the past 3 months (6.8% average weekly change). Reported Earnings • Nov 08
Second quarter 2026 earnings released: EPS: JP¥17.97 (vs JP¥17.33 in 2Q 2025) Second quarter 2026 results: EPS: JP¥17.97 (up from JP¥17.33 in 2Q 2025). Revenue: JP¥14.6b (up 2.9% from 2Q 2025). Net income: JP¥443.0m (up 3.7% from 2Q 2025). Profit margin: 3.0% (in line with 2Q 2025). Revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has remained flat. Buy Or Sell Opportunity • Oct 03
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 4.6% to JP¥793. The fair value is estimated to be JP¥658, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 8.7% in 2 years. Earnings are forecast to decline by 13% in the next 2 years. Buy Or Sell Opportunity • Sep 04
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 1.8% to JP¥794. The fair value is estimated to be JP¥659, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 8.7% in 2 years. Earnings are forecast to decline by 13% in the next 2 years. Announcement • Sep 03
Saint-Care Holding Corporation to Report Q2, 2026 Results on Nov 07, 2025 Saint-Care Holding Corporation announced that they will report Q2, 2026 results on Nov 07, 2025 Buy Or Sell Opportunity • Aug 12
Now 23% overvalued after recent price rise Over the last 90 days, the stock has risen 5.3% to JP¥811. The fair value is estimated to be JP¥658, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 3.7% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 8.7% in 2 years. Earnings are forecast to decline by 13% in the next 2 years. New Risk • Aug 09
New major risk - Revenue and earnings growth Earnings are forecast to decline by an average of 2.7% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 2.7% per year for the foreseeable future. Minor Risk Dividend is not well covered by cash flows (100% cash payout ratio). Reported Earnings • Jul 01
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: JP¥60.31 (down from JP¥81.13 in FY 2024). Revenue: JP¥56.3b (up 4.1% from FY 2024). Net income: JP¥1.49b (down 26% from FY 2024). Profit margin: 2.6% (down from 3.7% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.2%. Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 4% per year. Announcement • Jun 04
Saint-Care Holding Corporation to Report Q1, 2026 Results on Aug 08, 2025 Saint-Care Holding Corporation announced that they will report Q1, 2026 results on Aug 08, 2025 Reported Earnings • May 20
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: JP¥60.31 (down from JP¥81.13 in FY 2024). Revenue: JP¥56.3b (up 4.1% from FY 2024). Net income: JP¥1.49b (down 26% from FY 2024). Profit margin: 2.6% (down from 3.7% in FY 2024). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.2%. Revenue is forecast to grow 4.2% p.a. on average during the next 2 years, compared to a 4.4% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has fallen by 2% per year and the company’s share price has also fallen by 2% per year. Announcement • May 15
Saint-Care Holding Corporation, Annual General Meeting, Jun 26, 2025 Saint-Care Holding Corporation, Annual General Meeting, Jun 26, 2025. Buy Or Sell Opportunity • Apr 08
Now 23% overvalued The stock has been flat over the last 90 days, currently trading at JP¥734. The fair value is estimated to be JP¥595, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.6% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 8.3% in 2 years. Earnings are forecast to grow by 15% in the next 2 years. Announcement • Mar 27
Mitsubishi Corporation (TSE:8058) and Saint-Care Holding Corporation (TSE:2374) acquired an additional unknown stake in Care Design Institute Inc. from INCJ, Ltd. Mitsubishi Corporation (TSE:8058) and Saint-Care Holding Corporation (TSE:2374) acquired an additional unknown stake in Care Design Institute Inc. from INCJ, Ltd. on March 26, 2025.
Mitsubishi Corporation (TSE:8058) and Saint-Care Holding Corporation (TSE:2374) completed the acquisition of an additional unknown stake in Care Design Institute Inc. from INCJ, Ltd. on March 26, 2025. Upcoming Dividend • Mar 21
Upcoming dividend of JP¥30.00 per share Eligible shareholders must have bought the stock before 28 March 2025. Payment date: 30 June 2025. Payout ratio is a comfortable 40% but the company is paying out more than the cash it is generating. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.7%). Announcement • Mar 01
Saint-Care Holding Corporation to Report Fiscal Year 2025 Results on May 15, 2025 Saint-Care Holding Corporation announced that they will report fiscal year 2025 results on May 15, 2025 Announcement • Feb 28
internet infinity Inc. (TSE:6545) enter into a share transfer agreement to acquire Saint-Works Corporation from Saint-Care Holding Corporation (TSE:2374) for ¥750 million. internet infinity Inc. (TSE:6545) enter into a share transfer agreement to acquire Saint-Works Corporation from Saint-Care Holding Corporation (TSE:2374) for ¥750 million on February 27, 2025. A cash consideration of ¥750 million will be paid by internet infinity for 1000 shares.
For the period ending March 31, 2024, Saint-Works Corporation reported total revenue of ¥828 million, EBIT of ¥138 million and net income of ¥91 million. As of March 31, 2024, Saint-Works Corporation reported total assets of ¥860 million and total common equity of ¥690 million. The expected completion of the transaction is April 1, 2025. Reported Earnings • Feb 08
Third quarter 2025 earnings released: EPS: JP¥19.81 (vs JP¥28.04 in 3Q 2024) Third quarter 2025 results: EPS: JP¥19.81 (down from JP¥28.04 in 3Q 2024). Revenue: JP¥14.4b (up 5.4% from 3Q 2024). Net income: JP¥488.0m (down 30% from 3Q 2024). Profit margin: 3.4% (down from 5.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 1% per year whereas the company’s share price has fallen by 3% per year. Announcement • Jan 03
Saint-Care Holding Corporation to Report Q3, 2025 Results on Feb 07, 2025 Saint-Care Holding Corporation announced that they will report Q3, 2025 results on Feb 07, 2025 Declared Dividend • Nov 11
Dividend of JP¥27.00 announced Shareholders will receive a dividend of JP¥27.00. Ex-date: 28th March 2025 Payment date: 30th June 2025 Dividend yield will be 3.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (36% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 14% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. EPS is expected to grow by 50% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Nov 09
Second quarter 2025 earnings released: EPS: JP¥17.33 (vs JP¥23.83 in 2Q 2024) Second quarter 2025 results: EPS: JP¥17.33 (down from JP¥23.83 in 2Q 2024). Revenue: JP¥14.2b (up 4.6% from 2Q 2024). Net income: JP¥427.0m (down 28% from 2Q 2024). Profit margin: 3.0% (down from 4.3% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Sep 10
Saint-Care Holding Corporation to Report Q2, 2025 Results on Nov 08, 2024 Saint-Care Holding Corporation announced that they will report Q2, 2025 results on Nov 08, 2024 Reported Earnings • Aug 10
First quarter 2025 earnings released: EPS: JP¥15.42 (vs JP¥19.64 in 1Q 2024) First quarter 2025 results: EPS: JP¥15.42 (down from JP¥19.64 in 1Q 2024). Revenue: JP¥13.8b (up 3.0% from 1Q 2024). Net income: JP¥381.0m (down 21% from 1Q 2024). Profit margin: 2.8% (down from 3.6% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings. Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to JP¥728, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 15x in the Healthcare industry in Japan. Total loss to shareholders of 12% over the past three years. Buy Or Sell Opportunity • Jul 01
Now 19% overvalued Over the last 90 days, the stock has fallen 2.5% to JP¥866. The fair value is estimated to be JP¥725, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 8.6% per annum over the same time period. Buy Or Sell Opportunity • Jun 25
Now 21% overvalued Over the last 90 days, the stock has fallen 4.7% to JP¥880. The fair value is estimated to be JP¥725, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 5.9% over the last 3 years. Earnings per share has grown by 10%. For the next 3 years, revenue is forecast to grow by 5.6% per annum. Earnings are also forecast to grow by 8.6% per annum over the same time period. Announcement • Jun 15
Saint-Care Holding Corporation (TSE:2374) announces an Equity Buyback for 130,000 shares, representing 0.53% for ¥108.03 million. Saint-Care Holding Corporation (TSE:2374) announces a share repurchase program. Under the program, the company will repurchase up to 130,000 shares, representing 0.53% of its issued share capital (excluding treasury stock), for a total purchase price of ¥108.03 million. The shares will be repurchased at a price of ¥831 per share. The purpose of the program is to enable the implementation of flexible capital policies that improve capital efficiency and respond to changes in the business environment. As of March 31, 2024, the company had 24,719,085 issued shares (excluding treasury stock) and 279,648 treasury shares. Reported Earnings • May 19
Full year 2024 earnings: EPS misses analyst expectations Full year 2024 results: EPS: JP¥81.13 (up from JP¥68.85 in FY 2023). Revenue: JP¥54.1b (up 2.9% from FY 2023). Net income: JP¥2.01b (up 17% from FY 2023). Profit margin: 3.7% (up from 3.3% in FY 2023). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 13%. Revenue is forecast to grow 4.8% p.a. on average during the next 2 years, compared to a 5.5% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • May 17
Saint-Care Holding Corporation, Annual General Meeting, Jun 27, 2024 Saint-Care Holding Corporation, Annual General Meeting, Jun 27, 2024. Announcement • Mar 21
Saint-Care Holding Corporation to Report Fiscal Year 2024 Results on May 15, 2024 Saint-Care Holding Corporation announced that they will report fiscal year 2024 results on May 15, 2024 Upcoming Dividend • Mar 21
Upcoming dividend of JP¥25.00 per share Eligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 28% and this is well supported by cash flows. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.2%). Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: JP¥28.04 (vs JP¥18.83 in 3Q 2023) Third quarter 2024 results: EPS: JP¥28.04 (up from JP¥18.83 in 3Q 2023). Revenue: JP¥13.6b (up 2.6% from 3Q 2023). Net income: JP¥693.0m (up 48% from 3Q 2023). Profit margin: 5.1% (up from 3.5% in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Announcement • Nov 26
Saint-Care Holding Corporation to Report Q3, 2024 Results on Feb 08, 2024 Saint-Care Holding Corporation announced that they will report Q3, 2024 results on Feb 08, 2024 Reported Earnings • Nov 09
Second quarter 2024 earnings released: EPS: JP¥23.83 (vs JP¥15.92 in 2Q 2023) Second quarter 2024 results: EPS: JP¥23.83 (up from JP¥15.92 in 2Q 2023). Revenue: JP¥13.6b (up 3.0% from 2Q 2023). Net income: JP¥589.0m (up 48% from 2Q 2023). Profit margin: 4.3% (up from 3.0% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 8% per year whereas the company’s share price has increased by 5% per year. Announcement • Aug 30
Saint-Care Holding Corporation to Report Q2, 2024 Results on Nov 08, 2023 Saint-Care Holding Corporation announced that they will report Q2, 2024 results on Nov 08, 2023 Reported Earnings • Aug 09
First quarter 2024 earnings released: EPS: JP¥19.64 (vs JP¥19.82 in 1Q 2023) First quarter 2024 results: EPS: JP¥19.64 (down from JP¥19.82 in 1Q 2023). Revenue: JP¥13.4b (up 3.0% from 1Q 2023). Net income: JP¥485.0m (down 2.0% from 1Q 2023). Profit margin: 3.6% (down from 3.8% in 1Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Jun 02
Saint-Care Holding Corporation to Report Q1, 2024 Results on Aug 08, 2023 Saint-Care Holding Corporation announced that they will report Q1, 2024 results on Aug 08, 2023 Reported Earnings • May 17
Full year 2023 earnings: EPS exceeds analyst expectations Full year 2023 results: EPS: JP¥68.85 (down from JP¥73.51 in FY 2022). Revenue: JP¥52.6b (up 7.5% from FY 2022). Net income: JP¥1.71b (down 6.7% from FY 2022). Profit margin: 3.3% (down from 3.8% in FY 2022). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 3.1%. Revenue is forecast to grow 7.0% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 21% per year. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥24.00 per share at 3.2% yield Eligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 3.2%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%). Reported Earnings • Feb 12
Third quarter 2023 earnings released: EPS: JP¥18.83 (vs JP¥24.50 in 3Q 2022) Third quarter 2023 results: EPS: JP¥18.83 (down from JP¥24.50 in 3Q 2022). Revenue: JP¥13.3b (up 5.7% from 3Q 2022). Net income: JP¥468.0m (down 24% from 3Q 2022). Profit margin: 3.5% (down from 4.9% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.2% p.a. on average during the next 3 years, compared to a 5.9% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 21% per year whereas the company’s share price has increased by 18% per year. Announcement • Dec 11
Saint-Care Holding Corporation to Report Q3, 2023 Results on Feb 08, 2023 Saint-Care Holding Corporation announced that they will report Q3, 2023 results on Feb 08, 2023 Reported Earnings • Nov 18
Second quarter 2023 earnings released: EPS: JP¥15.92 (vs JP¥18.74 in 2Q 2022) Second quarter 2023 results: EPS: JP¥15.92 (down from JP¥18.74 in 2Q 2022). Revenue: JP¥13.2b (up 10.0% from 2Q 2022). Net income: JP¥398.0m (down 15% from 2Q 2022). Profit margin: 3.0% (down from 3.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Announcement • Nov 16
Saint-Care Holding Corporation (TSE:2374) announces an Equity Buyback for 300,000 shares, for ¥246.3 million. Saint-Care Holding Corporation (TSE:2374) announces a share repurchase program. Under the program, the company will repurchase up to 300,000 shares, representing 1.20% of its issued share capital (excluding treasury stock), for a total purchase price of ¥246.3 million. The shares will be repurchased at a price of ¥821 per share. The purpose of the program is to improve capital efficiency and implement agile capital policies in response to changes in the business environment. As of September 30, 2022, the company has 24,998,565 issued shares (excluding treasury stock) and 168 treasury shares. Board Change • Nov 16
Less than half of directors are independent There are 6 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 3 independent directors. 7 non-independent directors. Independent Outside Director Tomoya Shiraishi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: JP¥15.92 (vs JP¥18.74 in 2Q 2022) Second quarter 2023 results: EPS: JP¥15.92 (down from JP¥18.74 in 2Q 2022). Revenue: JP¥13.2b (up 10.0% from 2Q 2022). Net income: JP¥398.0m (down 15% from 2Q 2022). Profit margin: 3.0% (down from 3.9% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 7.0% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Healthcare industry in Japan. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Sep 26
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 6.5%. The fair value is estimated to be JP¥1,001, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 16% in 2 years. Earnings is forecast to grow by 35% in the next 2 years. Announcement • Sep 01
Saint-Care Holding Corporation to Report Q2, 2023 Results on Nov 08, 2022 Saint-Care Holding Corporation announced that they will report Q2, 2023 results on Nov 08, 2022 Reported Earnings • Aug 09
First quarter 2023 earnings released: EPS: JP¥19.82 (vs JP¥19.27 in 1Q 2022) First quarter 2023 results: EPS: JP¥19.82 (up from JP¥19.27 in 1Q 2022). Revenue: JP¥13.0b (up 11% from 1Q 2022). Net income: JP¥495.0m (up 2.9% from 1Q 2022). Profit margin: 3.8% (down from 4.1% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 7.7%, compared to a 4.6% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 27% per year whereas the company’s share price has increased by 24% per year. Announcement • Jun 02
Saint-Care Holding Corporation to Report Q1, 2023 Results on Aug 08, 2022 Saint-Care Holding Corporation announced that they will report Q1, 2023 results on Aug 08, 2022 Reported Earnings • May 19
Full year 2022 earnings: EPS misses analyst expectations Full year 2022 results: EPS: JP¥73.51 (up from JP¥59.60 in FY 2021). Revenue: JP¥48.9b (up 6.5% from FY 2021). Net income: JP¥1.84b (up 24% from FY 2021). Profit margin: 3.8% (up from 3.2% in FY 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.4%. Over the next year, revenue is forecast to grow 6.0%, compared to a 3.5% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Announcement • May 18
Saint-Care Holding Corporation, Annual General Meeting, Jun 28, 2022 Saint-Care Holding Corporation, Annual General Meeting, Jun 28, 2022. Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 1 was an independent director. The company's board is composed of: 2 independent directors. 7 non-independent directors. Independent Outside Director Tomoya Shiraishi was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Announcement • Apr 07
Saint-Care Holding Corporation to Report Fiscal Year 2022 Results on May 16, 2022 Saint-Care Holding Corporation announced that they will report fiscal year 2022 results on May 16, 2022 Upcoming Dividend • Mar 23
Upcoming dividend of JP¥20.00 per share Eligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (2.0%). Reported Earnings • Feb 09
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Third quarter 2022 results: EPS: JP¥24.50 (up from JP¥14.86 in 3Q 2021). Revenue: JP¥12.6b (up 7.2% from 3Q 2021). Net income: JP¥612.0m (up 65% from 3Q 2021). Profit margin: 4.9% (up from 3.2% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.0%. Earnings per share (EPS) also missed analyst estimates by 12%. Over the next year, revenue is forecast to grow 8.8%, compared to a 5.0% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Reported Earnings • Nov 10
Second quarter 2022 earnings released: EPS JP¥18.74 (vs JP¥22.23 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: JP¥12.0b (up 3.1% from 2Q 2021). Net income: JP¥468.0m (down 16% from 2Q 2021). Profit margin: 3.9% (down from 4.8% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 11
Investor sentiment improved over the past week After last week's 15% share price gain to JP¥1,057, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Healthcare industry in Japan. Total returns to shareholders of 71% over the past three years. Reported Earnings • May 17
Full year 2021 earnings released: EPS JP¥59.60 (vs JP¥33.43 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥45.9b (up 6.4% from FY 2020). Net income: JP¥1.49b (up 79% from FY 2020). Profit margin: 3.2% (up from 1.9% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year and the company’s share price has also increased by 13% per year. Upcoming Dividend • Mar 23
Upcoming dividend of JP¥16.00 per share Eligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. Trailing yield: 1.1%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.5%). Announcement • Mar 19
Saint-Care Holding Corporation to Report Fiscal Year 2021 Results on May 14, 2021 Saint-Care Holding Corporation announced that they will report fiscal year 2021 results on May 14, 2021 Valuation Update With 7 Day Price Move • Mar 12
Investor sentiment improved over the past week After last week's 20% share price gain to JP¥1,186, the stock is trading at a trailing P/E ratio of 19.8x, up from the previous P/E ratio of 16.4x. This compares to an average P/E of 18x in the Healthcare industry in Japan. Total returns to shareholders over the past three years are 71%. Is New 90 Day High Low • Mar 11
New 90-day high: JP¥1,108 The company is up 29% from its price of JP¥858 on 11 December 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is up 5.0% over the same period. Reported Earnings • Feb 10
Third quarter 2021 earnings released: EPS JP¥14.86 (vs JP¥12.69 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: JP¥11.7b (up 6.3% from 3Q 2020). Net income: JP¥371.0m (up 18% from 3Q 2020). Profit margin: 3.2% (up from 2.9% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 11% per year. Analyst Estimate Surprise Post Earnings • Feb 10
Revenue beats expectations, earnings disappoint Revenue exceeded analyst estimates by 0.2%. Earnings per share (EPS) missed analyst estimates by 2.2%. Over the next year, revenue is forecast to grow 4.7%, compared to a 8.0% growth forecast for the Healthcare industry in Japan. Is New 90 Day High Low • Jan 20
New 90-day high: JP¥957 The company is up 29% from its price of JP¥744 on 22 October 2020. The Japanese market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare industry, which is up 6.0% over the same period. Announcement • Dec 04
Saint-Care Holding Corporation to Report Q3, 2021 Results on Feb 08, 2021 Saint-Care Holding Corporation announced that they will report Q3, 2021 results on Feb 08, 2021 Announcement • Oct 06
Saint-Care Holding Corporation to Report Q2, 2021 Results on Nov 09, 2020 Saint-Care Holding Corporation announced that they will report Q2, 2021 results on Nov 09, 2020 
